Updated Jul 16, 2026
Mahmood Nadir is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $12K.

Nadir Mahmood is listed as President of Nkarta, Inc. in the company's SEC filing dated January 8, 2026. The filing shows no insider purchases or sales for that period, and Nkarta is described as a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-20 | NKTX | Nkarta, Inc. | S — Open-market sale | 5.6K | $2.07 | $12K |
| 2026-01-08 | NKTX | Nkarta, Inc. | A — Grant or award | 80.0K | $0.00 |
Nadir Mahmood is listed as President of Nkarta, Inc. in the company's SEC filing dated January 8, 2026. The filing shows no insider purchases or sales for that period, and Nkarta is described as a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($12K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mahmood Nadir profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.